Margolin

Biography

Alexey Margolin, Ph.D., is the co-founder and CEO of Allena Pharmaceuticals. He also cofounded, was president and CEO of Alcresta Pharmaceuticals where he currently serves on the Board of Directors. At Alcresta Dr. Margolin created the technology platform and spearheaded the development and regulatory approval of Relizorb,™ a first-of-its-kind digestive enzyme cartridge designed to break down fats in enteral tube feeding formula. Prior to Allena and Alcresta, Dr. Margolin co-founded Alnara Pharmaceuticals in 2008, where he was President and CEO until 2010 when the company was acquired by Eli Lilly. Previously Dr. Margolin also served as chief scientific officer of Altus Pharmaceuticals where he initiated and led several therapeutic programs based on protein crystallization technology. Dr. Margolin is an expert in the fields of protein drug development and enzymology. He is the author of more than 60 publications and is an inventor on several patents. In 2003, Dr. Margolin was elected fellow of the American Institute of Medicine and Biological Engineering. Dr. Margolin holds both his M.S. in chemistry and Ph.D. in bio-organic chemistry from Moscow University.

Research Interest

Enzyme therapeutics to treat metabolic conditions including hyperoxaluria and hyperuricemia